See Tai Sandi — SEC Form 4 filings

SEC reporting owner CIK 2009350. 7 Form 4 filings on record with FilingPulse; latest filed 2025-11-20.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2025-01-10 to 2025-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Lexeo Therapeutics, Inc. (LXEO)Chief Development Officer76 legs · 6,509 sh · $47,7044

Form 4 filings — See Tai Sandi

FiledFormIssuerReported transactionsSource
2025-11-204Lexeo Therapeutics, Inc. (LXEO)Sale (S): 386 @ $9.27EDGAR
2025-10-174Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 10,890 @ $0 · Sale (S): 3,844 @ $8.94 · Sale (S): 44 @ $9.56EDGAR
2025-08-204Lexeo Therapeutics, Inc. (LXEO)Sale (S): 382 @ $4.67EDGAR
2025-05-204Lexeo Therapeutics, Inc. (LXEO)Sale (S): 367 @ $2.77EDGAR
2025-04-094Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 5,720 @ $2.61EDGAR
2025-02-214Lexeo Therapeutics, Inc. (LXEO)Sale (S): 1,486 @ $4.41EDGAR
2025-01-104Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 38,750 @ $0 · Grant/award (A): 77,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2009350 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →